Navigation Links
Detecting miRNA & siRNA

Sensitive Solution Hybridization Assay For Small RNAs

In the past few years, interest in the identification, detection, and use of small RNA molecules has exploded. This interest has primarily stemmed from two interrelated lines of research. In one, small double-stranded RNAs (dsRNAs) called small interfering RNAs (siRNAs) have been used to silence the expression of specific genes at the post transcriptional level by a pathway known as RNA interference (RNAi). In the other, numerous small regulatory RNA molecules, referred to as microRNAs (miRNAs), have been shown to regulate target gene expression in various organisms. It is now becoming apparent that siRNAs and miRNAs are related molecules, sharing common processing pathways and maybe even functional mechanisms.

Currently, most miRNA researchers are analyzing miRNA expression patterns by Northern blot, a technique that is relatively insensitive and labor intensive. A few researchers performing gene silencing experiments also use this technique to analyze siRNA levels after RNAi induction, although the majority of researchers performing gene silencing experiments do not monitor siRNA levels at all. This may be due in large part to the inherent difficulties in detecting small RNAs with standard techniques. Here we discuss an optimized technique for the detection and quantitation of small RNAs. This technique allows easier monitoring of miRNA expression and siRNA levels in a variety of sample types and is considerably more sensitive than Northern analysis.

Solution Hybridization Improves Sensitivity
Because hybridization of probe to target in solution is more sensitive than hybridization on solid support (Northern analysis), Ambion investigated the solution based RNase protection assay for its ability to detect small RNAs. After modification of the hybridization conditions to maximize hybridization of short probes to their targets, the assay's ability to specifically detect small RNA molecules were analyzed.

To examine the sensitivity of the assay, decreasing amounts of a 21 nt RNA, corresponding to the antisense strand of an siRNA known to target GAPDH, were spiked into a yeast RNA sample and then analyzed by the solution hybridization method. In brief, the samples were mixed with a 29 nt high specific activity radiolabeled probe (5 x 104 cpm) and hybridization buffer. After heat denaturation, each mixture was incubated at 42C to hybridize the probe to the complementary siRNA target strand. Unhybridized RNA species and excess RNA probe were removed by a brief ribonuclease digestion. Protected target RNA fragments were recovered in the same tube using a reagent that simultaneously inactivates the ribonuclease and precipitates the nucleic acid. The protected RNA was then resuspended with gel loading buffer, analyzed on a denaturing polyacrylamide gel, and exposed to film. Figure 1A demonstrates that the assay was able to detect as little as 50 attomoles of the 21 nt target RNA after a two hour exposure.

Figure 1. Sensitive and Specific Detection of MicroRNAs. (A) The indicated amounts of a 21 nt antisense GAPDH siRNA were spiked into 4 g of yeast RNA and detected with the mirVana miRNA Detection Kit using a 29 nt long probe prepared with the mirVana miRNA Construction Kit. Protected RNA fragments (19 nt) were analyzed on a 15% denaturing polyacrylamide gel. (B) The same experiment as in Panel A with 200 attomoles of sense or antisense GAPDH siRNA radiolabeled probes specific for each strand.

Specificity of the Assay
Any assay for small RNAs must show specificity for the target molecule. Thus, the assay's specificity was investigated. As shown in Figure 1B, radiolabeled probes specific for the antisense strand of GAPDH siRNA detected only the corresponding target RNA. No signal was detected in the absence of target or in the presence of the sense strand of the GAPDH siRNA. Furthermore, the assay yielded no detectable background (e.g. nonspecific hybridization to yeast RNA molecules).

To further investigate assay specificity, miR-16 miRNA was detected in mouse kidney total RNA using three different probes. One probe was perfectly complementary to the target (miR-16), a second included three mismatched nucleotides (mir-16 mut), and a third included four additional A residues between the 22 nt sequence complementary to mir-16 and the leader sequence (mir-16 + 4). The mir-16 and mir-16 + 4 probes were both able to detect miR-16 miRNA in the RNA sample, wh ereas the signal was completely abolished with mir-16 mut probe (Figure 2). This result demonstrates that the assay has the required specificity for detecting small RNAs in total RNA samples.

Detecting Multiple Small RNAs in the Same Sample
Figure 2 also shows that the assay can be used for multi-target detection. The four A residues added to the mir-16 probe between the complementary region and the leader sequence (which is necessary to distinguish protected from unprotected probe) are not cleaved by the mixture of RNases used in the assay. They thus increase the size of the protected fragment by four nucleotides. This probe (mir-16 +4) can be used in the presence of another probe with the same length complementary region but lacking the additional A residues (mir-22) for multi-target detection (Figures 2 and 3). Adding multiple A residues to a small RNA probe sequence permits the detection of more than one small RNA in a single sample giving this assay a distinct advantage over Northern analysis for detecting multiple small RNA molecules that have the same size.

Figure 2. miRNA Expression in Mouse Kidney Total RNA. miR-16 and miR-22 expression was analyzed as in Figure 1 with 1 g of FirstChoice Total RNA from mouse kidney and 32 nt long probes generated with the mirVana miRNA Probe Construction Kit. mir-16 mut probe (32 nt) carries 3 mismatch mutations (ACG to CGA) corresponding to nucleotides 9 to 11 of the miR-16 miRNA sequence. The mir-16+4 probe (36 nt) carries 4 additional A residues between the 22 nt sequence specific for miR-16 and the 10 nt leader sequence, producing a 26 nt lo ng protected fragment, which is 4 nt longer than that produced by the mir-16 and mir-22 probes.

Figure 3. Single and Multiple Target Detection. The indicated target RNAs were detected in 500, 250, 100 and 50 ng of total RNA from mouse tissues (3.5 hours exposure) or HeLa cells (6 hours exposure) as described in Figures 1 and 2. The probe specific for GAPDH mRNA (39 nt) produces a 29 nt long protected fragment with the same specific activity as the mir-16 protected fragment. miR-16 was detected with the mir-16 +4 probe.

Analysis of miRNA Expression Patterns Across Various Tissue Types
The function of most miRNAs is not known; however, a number of miRNAs seem to be involved in post-transcriptional gene regulation. Some of these miRNAs (e.g. lin-4 and let-7) inhibit protein synthesis by binding to the 3' untranslated region of target mRNAs. Others bind to perfectly complementary mRNA sequences to destroy target transcripts (e.g. Scarecrow miRNA in plants). These miRNAs, therefore, function like siRNAs and could be classified as such. Bantam, lin-4 and let-7 have also been shown to play critical roles in tissue development. Other miRNAs are believed to have similar functions because of their differential spatial and temporal expression patterns.

We used the solution hybridization assay to monitor the differential expression of two different miRNAs across mouse tissues (Figure 4). High levels of mir-16 expression were detected in all five tissues tested, with the highest expression levels evident in lung and thymus. These variations across tissues were confirmed by Northern blot analysis with the same mir-16 probe. Interestingly the mir-22 probe showed a completely different pattern of expression. miR-22 was highly expressed in lung and ovary and was present in spleen, thymus, and testicle at levels that would not have been detectable with standard Northern blotting techniques (data not shown). The relative abundance of miR-16 and miR-22 miRNA in mouse lung was also confirmed by multi-target detection with the simultaneous use of the mir-16+4 and mir-22 probes in the assay (Figure 3).

Figure 4. miR-16 and miR-22 Expression in Mouse Tissues. miR-16 and miR-22 miRNAs (22 nt) were detected in 1 g of FirstChoice Total RNA from five different mouse tissues using 32 nt long mir-16 or mir-22 probes generated with the mirVana miRNA Probe Construction Kit. The same differential expression of miR-16 across tissues was observed by Northern blot analysis (2 days exposure) or by hybridization in solution (2 hr exposure). RNAs were analyzed on 15% denaturing polyacrylamide gels. As a loading control, the same RNA samples were resolved on a 1.2% denaturing agarose gel and U1 snRNA expression was analyzed by Northern blot.

Detecting Small RNAs and mRNAs in the Same Sample
In many cases, it may be desirable to simultaneously detect small RNAs such as miRNA or siRNA with one or more mRNAs. To determine if the assay was compatible with this application, an antisense probe to GAPDH mRNA was designed to generate a protected RNA fragment slightly lo nger (29 nt) than the protected fragment generated by the mir-16 probe (22 nt). These probes were then used to simultaneously detect miR-16 miRNA and GAPDH mRNA in total RNA from HeLa cells (Figure 3). The results indicate that both targets are easily detected, and that surprisingly, the level of miR-16 in HeLa cells is greater than that of GAPDH mRNA, a transcript that is known to be highly abundant.

Simultaneous Detection of siRNA Expression and Target Gene Knockdown
For the development of improved siRNA delivery systems and siRNA expression vectors, particularly those that permit targeted delivery or tissue specific expression, researchers need to monitor siRNA levels -- preferably in conjunction with the assessment of target transcript down regulation. To determine if the solution based assay permitted correlation of expressed siRNA levels and targeted mRNA knockdown, probes were generated to a GAPDH siRNA known to effectively reduce GAPDH expression, and to the GAPDH mRNA target. An expression vector (pSilencer 2.0-U6) engineered to express either the GAPDH siRNA or a scrambled control siRNA was transfected into HeLa cells. Three days after transfection, total RNA was isolated and the solution hybridization assay was performed. Using the assay, it was possible to simultaneously detect siRNA expressed from the vector (Figures 3 and 5A), as well as the GAPDH mRNA (Figure 5B). As expected, the GAPDH mRNA levels were found to be reduced considerably (~60%) in cells transfected with the GAPDH siRN A vector as compared to cells transfected with the negative control vector (Figure 5B). In addition, the GAPDH siRNA was only detected in the cells transfected with the GAPDH siRNA expressing vector. The specific reduction of GAPDH mRNA expression was similar (~55%) when analyzed by Northern blot.

Figure 5. Analysis of GAPDH siRNA Expression and mRNA Knockdown.(A) HeLa cells were transfected with pSilencer 2.0-U6 engineered to express either an siRNA targeting GAPDH or a negative control siRNA (SCR). Three days after transfection, total RNA was isolated and 1 g was assessed using the mirVana miRNA Detection Kit. Probes to the antisense strand of the GAPDH siRNA were prepared as described in Figure 1. (B) Same experiment with probes specific for GAPDH mRNA or GAPDH siRNA. Both probes had the same specific activity. As a control, GAPDH mRNA expression was also analyzed by Northern blot.

Advantages of the Solution Hybridization Assay
The experiments presented here indicate that the solution hybridization assay based on ribonuclease protection can sensitively and specifically detect small RNAs such as miRNAs and siRNAs. Quantitative analyses can be performed in solution with as little as 10-50 ng of total RNA to detect attomole (10-18 mol) amounts of target RNA. In general, solution hybridization with short RNA probes is 100500 times more sensitive than membrane hybridization. Another advantage of this assay is the potential to simultaneously detect several small RNAs of the same size or both small RNA and longer RNA species (e.g. siRNA and target messenger RNA) from a single sample.

Ambion makes this solution hybridization assay available as the mirVana miRNA Detection Kit (see Detecting Attomole Amounts of Small RNA). We also offer the mirVana miRNA Probe Construction Kit, for the easy preparation of short RNA probes for this assay as well as for Northern analysis and in situ hybridization (see Prepare siRNA and miRNA Probes in Just 1 Hour).

back to top

Ordering Information
Cat# Product Name Size 1550 mirVana miRNA Probe Construction Kit 30 rxns 1552 mirVana miRNA Detection Kit 100 rxns 7778 Decade Markers 10 rxns


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue
2. Tools for Detecting MSH2 Expression in Chinese Hamster Ovary Cells
3. Two-dimensional Optimization of a Semi-nested PCR for Detecting Listeria monocytogenes
4. Detecting Attomole Amounts of Small RNA
5. Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform
6. miRNA Expression in White Blood Cells
7. Isolate It All: siRNA miRNA Total RNA Native Protein
8. Get the miRNA OutPlant Applications
9. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
10. pSilencer 4.1-CMV: Versatile Vectors for Expression of siRNA, miRNA, and mRNA
11. Precursor miRNAs for Successful miRNA Functional Studies
Post Your Comments:

(Date:10/12/2015)... , ... October 12, 2015 , ... ... that Dr. Srini Srinivasan, has joined the firm as a Premier Expert consultant. ... stature enable them to bring extraordinary value to the company's clients. Premier ...
(Date:10/11/2015)... ... 2015 , ... Intelligent Implant Systems, LLC is pleased to ... have been completed with this new posterior thoracolumbar spinal fusion system. The surgeries ... the Carolinas. The Revolution™ Spinal System pioneers a new approach to lumbar ...
(Date:10/9/2015)... ANNAPOLIS, Md. , Oct. 9, 2015 ... entered into the Congressional Record her statement recognizing the ... celebrated October 11-17. IPAW is sponsored by the ... companies, and is designed to:   , Raise ... contributions of plasma donors in saving and improving lives ...
(Date:10/9/2015)...  DePuy Synthes Trauma* announced today the U.S. launch ... Technology**, the only pre-hydrated demineralized cancellous bone tissue matrix ... ankle, hand and wrist), including fusion, and for filling ... 2015 Orthopaedic Trauma Association (OTA) Annual Meeting. ... bone growth) and osteoinductive 2,3 (stimulates new bone ...
Breaking Biology Technology:
(Date:9/24/2015)... 24, 2015 Publiceringsförbud ... Kerv ( ), ... idag världens första kontaktlösa betalningsring på ... 000 GBP för massproduktion via crowdfunding.  ... , Kerv-bärare kan göra direkta ...
(Date:9/10/2015)... 10, 2015 Report Details ... Selling Opportunities and Revenue Prospects to Help You ... biologics, especially new drug classes? Get the latest ... with exclusive market data and industry knowledge, benefitting ... results, opportunities and sales predictions. Visiongain,s new ...
(Date:9/10/2015)... Sept. 10, 2015 Pursuant Health has ... to create an interactive, image-based health risk assessment ... wellness kiosk.  The unique assessment quantifies user results ... that suggests an individual,s biological age based on ... measured by the kiosk. Comprised of ...
Breaking Biology News(10 mins):